Abu Dhabi’s state-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based ...

This collaboration brings together Syndesis Health’s extensive phenotype database and ADHDS’s cutting-edge digital health ...

The initiative aligns with Abu Dhabi’s broader vision to become a world-class destination for health innovation and economic ...

M42 and Juvenescence will harness the power of artificial intelligence, genomics, and biobanking to accelerate clinical ...

Abu Dhabi has taken a groundbreaking step in personalised healthcare by integrating APOE genetic testing for Alzheimer’s ...

The Innovation Hub will serve as a catalyst for digital health transformation, fostering the growth of startups, driving ...

Shutterstock Abu Dhabi: Abu Dhabi-backed health-care investment company M42 has taken a stake in biotech startup Juvenescence, a UK-based firm focused on developing drugs to expand human lifespans.

Together with the Fatima bint Mubarak Center, this state-of-the-art facility further underscores Cleveland Clinic Abu Dhabi’s position as a leader in oncology advancements and personalized care, ...

M42 signed a strategic partnership with Toshiba to introduce the first heavy-ion therapy in the UAE and the Middle East ...

The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership with ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare. In collaboration ...